Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect” (Europe/Austria)ext Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, July 11, 2016

Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect” (Europe/Austria)ext



open access:
Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect” Austria
 

Conclusions

In this present study we could demonstrate that particularly younger and female participants with high educational level attended significantly more often genetic counseling for HBOC. Increased presence of HBOC in media since AJ’s disclosure of carrying a BRCA mutation had lead that information and awareness about HBOC was obtained by a wider audience from different social background.

Background

In Europe, breast cancer is the most frequently diagnosed cancer in women with 464 000 new cases diagnosed in 2012 [1]. Generally, lifetime-risk of developing breast cancer (BC) is about 12-13 % [2]. BC is mainly a sporadic disease and only 7-15 % of all BC cases are thought to be inherited [3, 4]. About 40-60 % of hereditary breast and ovarian cancers (HBOC) are due to the presence of germline mutations in the breast cancer susceptibility genes type 1 and 2 (BRCA1 and BRCA2) [5]. BRCA mutations are associated with early onset disease and distinct elevated risk of developing BC and ovarian cancer (OC) [6]. The cumulative lifetime risk of BRCA1 mutation carriers is up to 85 % for BC and 20-40 % for OC, whereas BRCA2 mutations carriers have somewhat lesser risk for BC (45-84 %) and a risk up to 31 % for OC [7, 8, 9, 10, 11].
Genetic counseling and testing for BRCA1 and BRCA2 mutations is recommended for members of families with familial clustering of BC and/or OC. In Austria, clients have to fulfill specific criteria of medical and / or familial history to enable insurance covered genetic testing. Therefore, individual guidelines exist [12, 13]. Identification of subjects at risk for HBOC is necessary in order to offer distinct strategies to deal with this elevated risk. First, intensified surveillance to allow earlier cancer detection can be offered. Furthermore, risk reducing procedures like bilateral mastectomy and / or salpingo-oophorectomy are obtainable [14, 15].....

0 comments :

Post a Comment

Your comments?